Skip to content

Our client asked:

Our client was interested in assessing the technical and commercial potential of novel biomanufacturing technologies to provide more sustainable sources of next generation biomaterials for their products in the future.

The project story:

  • Sagentia Innovation investigated which existing or nascent biomanufacturing approaches have potential for large-scale, commercially viable biomaterials production in 10-20 years and assessed what are the main challenges that remain to be addressed
  • Each solution was evaluated for its potential to enable cost-effective, sustainable and large-scale biomaterials production
  • Solutions were assessed to consider how they address key challenges and to evaluate their relative strengths
  • The IP of biomanufacturing technologies from prioritised organisations was assessed and complimented by a review of relevant consortia and funding initiatives that are relevant to biomaterials, to identify commercial opportunitiesInsights and conclusions were validated and enriched through interviews with key opinion leaders in the field

 

Client benefit:

Sagentia Innovation delivered a report summarizing key insights into biomanufacturing, including technology maturity, common challenges, and strategic recommendations to support the client’s product portfolio

Our analysis helped the client understand key IP holders and the broader biomanufacturing ecosystem, including funding, consortia activity, and academic partnerships.

Could biomanufacturing unlock more sustainable materials for your future products?

Our experts can help you assess emerging technologies, understand the innovation ecosystem and identify the most promising opportunities for your organisation.